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Policies for the Treatment of Chronic Renal 
Failure: The Question of Feasibility 
Giandomenico Majone 
Methodological Introduction and Some Tentative Conclusions 
The large scale treatment of chronic renal failure (CRF) 
raises policy problems and medico-social dilemmas that are 
becoming increasingly common in many sectors of modern medical 
care. Medical research and technological advances, symbolized 
by artificial dialysis and kidney transplantation, make it 
possible to prolong the lives of thousands of patients who 
would otherwise die in a few weeks or months. 
But only a minority of CRF patients can be restored to a 
normal life, at least for some years. Most of the lives that 
are saved are really "half lives," full of pain and anxiety, 
that can be maintained only at an extraordinary cost to the 
community. From the point of view of the health planner, 
medical progress, short of a real breakthrough, can aggravate 
the problem, by increasing the stock of chronic patients. 
Here, as in other cases, modern medicine's technical 
capabilities have outstripped its resources and the ability 
of governments to face the social and ethical issues involved. 
It would be wrong to think that financ'ial limitations are the 
only, or even the most important, constraints facing the dif- 
ferent decision makers (health manager, physician, patient) 
in this case. Actually, the relaxation of financial constraints, 
would make other constraints, e.g. the supply of cadaver kid- 
neys, even more binding. 
Up to the present time, treatment of chronic uremic pa- 
tients, by dialysis or by transplantation, has been largely 
reserved to the fifteen to sixty years age group; but it is 
estimated that about 755 of all such patients are older than 
sixty years. A situation where social security, or similar 
institutional arrangements, would cover all the permanently 
disabled regardless of age, would produce not only an enor- 
mously increased demand of medical services, but even a quali- 
tative change in problems of patient care and rehabilitation. 
This is precisely the situation toward which several countries, 
including the United States, are now moving. Cost-effectiveness 
calculations an'd policy recommendations made in a period when 
patients were carefully screened (see section 3, below) lose 
much of their significance in the new context. 
It is the purpose of the present report to discuss the 
feasibility of a policy that would provide full treatment to 
all "medically suitable" CRF patients. This is done by inves- 
tigating the constraints set by the present level of scientific 
and technical knowledge, by institutional factors, and by 
resource limitations. My conclusion (a tentative one, since 
the numerical implications of the model developed in the last 
part of this paper have not yet been fully explored) is that 
such a policy is infeasible under present conditions, more a 
medical utopia than a public program capable of actual imple- 
mentation. Some form of patient selection would take place, 
under the cover of medical suitability; and it may be argued 
that a disguised form of rationing is less desirable, both on 
efficiency and on equity grounds, than one which frankly 
recognizes the existence of the constraints. 
Some advocates of a comprehensive policy for chronic renal 
disease have placed their hopes in transplantation as the op- 
timal form of treatment, and in home dialysis as a sort of 
second-best solution. Large scale transplantation would have 
to rely largely on cadaver kidneys, but it seems highly un- 
likely that all the medical, logistical, and legal problems 
involved in the procurement, storage, and utilization of the 
organs can be solved in the near future. 
Home dialysis is considerably cheaper than institutional 
dialysis, and it can improve the quality of life of the patient 
in several important respects. However, its superiority, in 
terms of survival rates, has never been satisfactorily esta- 
blished, and increasing experience with its long-term problems 
has somewhat dampened the initial enthusiasms. If it is true 
that "home dialysis should be restricted to patients who are 
well motivated, can return to work, are intelligent, have a 
stable and supportive spouse, and are middle or upper middle 
income bracket" (De Palma [13]), the proportion of patients 
that are suitable candidates for this mode of treatment cannot 
be very large. Different authors have given estimates of 10% 
(Leach [28]), 20% (De Palma [13]), and less than 40% (Schupak 
[45]), of all patients that are medically suitable for dialysis. 
One writer who had given an estimate of 70% in 1970, had lower- 
ed that value to 35% two years later, presumably on the basis 
of more extensive experience (Friedman and Kountz [161). 
According to the United States National Dialysis Registry, of 
the 7,305 patients known to be on dialysis as of January 1, 1973, 
37% were on home dialysis. As a national average this is quite 
high (considerably higher than that of most European countries, 
with the notable exception of Great Britain), and in view of 
the arguments to be presented below, see in particular section 
2.4, it may be doubted that such a proportion can be maintained 
in the long run (in fact, it was 41% in 1972). 
Another school of thought, acknowledging the impossibility 
of treating large numbers of CRF patients by present methods, 
maintains that prevention offers the only hope of significantly 
alleviating the problem of chronic renal disease; see especially 
A Report to the Surgeon General by the U.S. Department of Health, 
Education, and Welfare [501. Unfortunately, so little is known 
about the. natural histories of the diseases which most commonly 
lead to a condition of chronic uremia, that the entire popula- 
tion must be taken as the population at risk. Hence, high costs 
and great uncertainties about the results, rule out any massive 
preventive program at the present time; although early diagnosis 
and treatment of particular groups at risk appear to be cost- 
effective program,components, especially if carried out in con- 
junction with other types of screening. 
In sum, the only form of treatment available, now and in 
the near future, to most CRF patients is institutional dialysis, 
with its high costs and limited rehabilitation capabilities. 
In the following pages, the different constraints briefly dis- 
~ussed in this introduction, are examined in greater detail, 
and a model is developed which enables us to estimate the case 
load of dialysis patients, in the short or medium term, and 
in a steady state situation. Numerical applications of the 
model will be reported in a separate paper. 
One final point should be made here, in order* to avoid 
misunderstandings of the methodology used in this study (for 
a more detailed discussion of the general methodological issues 
involved, see Majone [ 3 4 ] ) .  The emphasis on feasibility con- 
siderations, on the constraints and uncertainties surrounding 
a policy problem, should not be interpreted as a defeatist 
attitude on the part of the analyst. Just as it is the essence 
of the scientific method to submit theories and hypotheses to 
the most stringent logical. and empirical tests, so, I would 
argue, it is the professional duty of the policy analyst to 
examine critically the conditions of feasibility of any proposed 
course of action. In both cases, criticism does not imply 
resignation to the complexities of our physical or social en- 
vironment; on the contrary, it is the necessary premise to 
better understanding and more incisive action. 
I. Epidemiological Asnects of Chronic Kidney Disease 
1.1. Natural History 
Chronic renal failure is defined as a disease process 
which involves a slowly progressive loss of nephrons, frequent- 
ly accompanied by vascular narrowing, with clinically irrever- 
sible impairment of kidney function. Once a patient reaches 
the irreversible state, he dies in a few months, unless he is 
treated by dialysis or transplantation. 
Very little is known about the natural histories of the 
diseases that may progress to CRF. Of the most frequent patho- 
logical diagnoses in patients' dying with chronic uremia from 
primary kidney disease, i.e. chronic pyelonephritis, chronic 
glomerulonephritis, and polycystic disease of the kidney, 
the first two are asymptomatic for many years. As for poly- 
cystic disease of the kidney, this is apparently a hereditary 
condition whose pattern of inheritance is that of a recessive 
character in the infantile form, and of a predominant trait 
in adults. 
Great uncertainty also surrounds the causal connections 
between renal failure and other pathological conditions. For 
instance, a recent longitudinal study covering a period of 
eight years for a group of 8,641 original examinees (Perlman 
et al. [401), suggests only a limited relationship of urinary- 
tract infections to renal failure. Hypertension was found in 
no more than the expected frequency for the population at 
large, despite its common association with renal disease. 
In fact, the probability of transition to a state of CRF 
is unknown even in the case of persons who have had an acute 
renal disease, such as acute pyelonephritis or glomerulo- 
nephritis. 
1.2. Feasibility of Prevention 
The present state of knowledge concerning the natural 
history of the disease sets severe constraints on preventive 
programs. In the words of the Committe on Chronic Renal 
Disease (Gottschalk [191), "consideration of prevention of 
chronic uremia is complicated by the uncertain relationship 
of the various acute and chronic diseases of the kidney and 
urinary tract to the end-stage kidney which produces the syn- 
drome of chronic uremia." More specifically, the Committee 
has taken the position that "it is impossible to predict what 
effect a massive program aimed at the early diagnosis and 
treatment of urinary tract infection would have on the inci- 
dence of chronic uremia," and that "problems relating to the 
prevention of chronic glomerulonephritis are in the nature of 
investigative issues and a massive prophylactive program aimed 
at the prevention of chronic uremia by the early diagnosis 
and treatment of streptococcal sore throats is not a reasonable 
proposal at this time." 
Also the Report to the Surgeon General of the U.S. 
Department of Health, Education, and Welfare [50], although 
more hopeful than the Gottschalk Committee about the possi- 
bility of significantly diminishing the annual reservoir of 
patients with irreversible renal failure through a vigorous 
program of screening, had to admit that "in the area of hyper- 
sensitivity diseases involving the kidney there appears to be 
no promising mode of attack in sight except for the launching 
of a systematic research effort." 
But while a general policy of prevention seems to be out 
of the question at the present time, recent epidemiological 
research suggests that preventive programs for limited sections 
of the population at risk may be feasible and reasonably cost- 
effective. One possible target group is that of the relatives 
of chronic uremic patients. In a study conducted at the 
University of Minnesota Hospitals (Spanos et al. [47]), the 
families of 200 patients awaiting renal transplantation, were 
examined for evidence of renal disease. If was found that 22% 
of the families of patients with renal failure had a history 
of renal failure in other members, a very much higher prevalence 
than that observed in the population at large. Intensive exami- 
nation of 209 potential related donors suggested that apparently 
healthy, symptom-free relatives of CRF patients have an extreme- 
ly high frequency of underlying renal disease. 
Several studies of bacteriuria have shown that hospital 
patients, diabetics, pregnant women, and school girls have a 
significantly greater frequency of asymptomatic bacteriuria 
than control populations (Brumfitt and Reeves [9]). It has 
been calculated that a prevention program directed at these 
target groups could reduce mortality due to kidney disease 
by 1%, mostly through the possibility of successful treat- 
ment of acute pyelonephritis, before severe tissue damage 
has occurred (U.S. Department of Health, Education, and 
Welfare [50]). Since the costs of a detection test (such as 
a Greiss test), a confirmatory test (urine culture, colony 
count, sensitivity test), and treatment are not too high 
(perhaps $20 for patients already under physicians' care), it 
appears that among all possible community prevention programs 
for the reduction of the frequency of chronic renal disease, 
those concerned with bacteriuria and pyelonephritis in chil- 
dren, pregnant women, and diabetics are the most cost-effective. 
However, given our limited knowledge about the relation between 
bacteriuria and chronic renal disease, the effectiveness, in 
absolute terms, of all such programs may very well be questioned. 
1.3. Incidence 
Incidence and prevalence of CRF can be estimated by direct 
surveys, by examination of hospital admission rates, from the 
incidence and prevalence of individual renal diseases and, 
most commonly, from mortality statistics. Unfortunately, the 
uncertainty about the natural history of the CRF condition, 
strongly affects the reliability of these estimates. All the 
indicated methods of estimation have disadvantages but, on 
balance, mortality statistics are the least unreliable source 
of information. In general, such statistics will lead to 
underestimates of true incidence and prevalence, since they 
do not indicate those who died from another disease where CRF 
was related as a significant factor, or those with CRF who died 
from other causes, especially cardiovascular. On the other 
hand, they may list deaths from genitourinary conditions which 
were n o t  severe o r  c h r o n i c  enough t o  q u a l i f y  a s  CRF. For  i n -  
s t a n c e ,  t h e  U.S. N a t i o n a l  Hea l th  Survey g roups  k idney  d i s e a s e  
t o g e t h e r  w i t h  o t h e r  d i s e a s e s  under  t h e  s i n g l e  c a t e g o r y  heading 
o f  G e n i t o u r i n a r y  D i s o r d e r s .  But t h e  p r o p o r t i o n  of  g e n i t o u r i n a r y  
d i s o r d e r s  which l e a d s  t o  c h r o n i c  uremia i s  unknown, and w i l l  
v a r y  w i t h  t h e  b r e a d t h  o f  d e f i n i t i o n  adopted  f o r  t h i s  group of  
d i s e a s e s .  Moreover, one canno t  assume t h a t  n e p h r i t i s  and 
n e p h r o s i s  r e p r e s e n t  t h e  same p r o p o r t i o n  of r e p o r t e d  g e n i t o -  
u r i n a r y  d i s o r d e r s  a s  t h e y  do o f  g e n i t o u r i n a r y  d e a t h s ,  s i n c e  
t h e  c a s e - f a t a l i t i e s  r a t e s  a r e  d i f f e r e n t .  The f a c t  t h a t  d i f -  
f e r e n t  c o u n t r i e s  g roup  t h e  c a t e g o r i e s  d e f i n e d  by the I n t e r n a -  
t i o n a l  S t a t i s t i c a l  C l a s s i f i c a t i o n  of Causes of  Death (ISCD) 
i n  d i f f e r e n t  ways, a l s o  c r e a t e s  problems,  e s p e c i a l l y  f o r  i n t e r -  
n a t i o n a l  comparisons.  
I n  a d d i t i o n ,  s i n c e  t h e  CRF p a t i e n t  d i e s  i n  a few months, 
u n l e s s  t r e a t e d  by d i a l y s i s  o r  t r a n s p l a n t a t i o n ,  t h e  d i s t i n c t i o n  
between p r e v a l e n c e  ( s t o c k )  and i n c i d e n c e  ( f l o w )  i s  r a t h e r  am- 
biguous  h e r e ,  e s p e c i a l l y  f o r  d a t a  c o l l e c t e d  b e f o r e  t h e s e  forms 
of t r e a t m e n t  had a s i g n i f i c a n t  impact  on t h e  t o t a l  numbers of 
c h r o n i c  r e n a l  p a t i e n t s .  T h i s  h a s  caused a  c e r t a i n  c o n f u s i o n  
i n  t h e  l i t e r a t u r e :  f o r  i n s t a n c e ,  McCormick and Navarro [32]  
i n t e r p r e t ,  i n  terms of  p r e v a l e n c e ,  t h e  e s t i m a t e s  o f  i n c i d e n c e  
worked o u t  by the G o t t s c h a l k  Repor t .  
The p r e c e d i n g  remarks are probab ly  s u f f i c i e n t  t o  e x p l a i n  
why c u r r e n t  estimates of t h e  i n c i d e n c e  of c h r o n i c  uremia v a r y ,  
between twenty  and f o r t y  p a t i e n t s  p e r  100,000 p o p u l a t i o n ,  some 
estimates b e i n g  as h i g h  a s  200/100,000 ( D r .  Traeger ,  Lyon) 
and 533/100,000 ( D r .  A l w a l l ,  Sweden). The we igh t  of  ev idence  
f a v o r s  v a l u e s  i n  t h e  20-25/100,000 range .  Such v a l u e s  have 
been o b t a i n e d  from American and European m o r t a l i t y  s t a t i s t i c s ,  
and i n  many c a s e s  have been v a l i d a t e d  by s u r v e y s  and examina- 
t i o n  of  m o r b i d i t y  rates.  Thus, accord ing  t o  d a t a  c o l l e c t e d  
by t h e  Research T r i a n g l e  I n s t i t u t e  (U.S. Department of  H e a l t h ,  
Educa t ion ,  and Welfare  [ 5 0 1 ) ,  a b o u t  50,000 peop le  d i e  as a 
r e s u l t  o f  uremia each  y e a r  i n  t h e  Uni ted  S t a t e s .  The c o r r e -  
sponding ra te  of  a b o u t  25/100,000 has  been c o n s i d e r e d  r a t h e r  
c o n s e r v a t i v e  by some a u t h o r i t i e s .  On t h e  o t h e r  hand, t h e  
c r u d e  d e a t h  ra te  from pr imary  k idney d i s e a s e  i n  t h e  Uni ted  
S t a t e s  i n  1969 was 14.3/100,000. When one adds  a p p r o p r i a t e  
p r e c e n t a g e s  of  t h e  d e a t h s  due t o  o t h e r  d i s e a s e s  i n v o l v i n g  
t h e  k idney ( e . g .  h y p e r t e n s i v e  d e a t h s  w i t h  a r t e r i o r a l  nephro- 
s c l e r o s i s ,  c o r r e s p o n d i n g  t o  ISCD code numbers 442 and 4 4 6 ) ,  
t h e  i n c i d e n c e  ra te  approaches  t h e  v a l u e  o f  20/100,000. 
A m a i l  s u r v e y  of a l l  d o c t o r s  p r a c t i c i n g  i n  t h e  S o u t h e a s t  
H o s p i t a l  Board of  S c o t l a n d ,  c a r r i e d  o u t  by t h e  S c o t t i s h  Home 
and H e a l t h  Department i n  1968-69, gave a r a t e  o f  n i n e t e e n  CRF 
p a t i e n t s  p e r  100,000 p o p u l a t i o n  (McCormick and Navarro [ 3 2 ] ) .  
An i n c i d e n c e  ra te  of 18/100,000 w a s  de te rmined  by a s t u d y  
o f  I s rae l i  m o r b i d i t y  d a t a  d u r i n g  t h e  two y e a r  p e r i o d  1965-66 
(Modan e t  a l .  [ 3 7 ] ) .  T h i s  c e r t a i n l y  u n d e r e s t i m a t e s  t h e  
incidence in the entire population, since only patients whose 
age did not exceed sixty years were counted; but the error is 
partly compensated by the fact that in the Israeli study, the 
condition of CRF was quantified in terms of blood urea (BU), 
the level being set at 60 mg%, against the 100 mgX level used 
in the Scottish study. 
1.4. Incidence of Patients Reuuirinq Treatment 
For the purpose of the present discussion, knowledge of 
the number of terminal renal patients who might benefit from 
treatment by intermittent dialysis, with or without transplanA 
tation, is even more important than that of general incidence 
rates. However, estimates of "needs" vary even more widely, 
being influenced by the availability of facilities and manpower, 
by the age groups considered, and by the admission criteria 
adopted by the different dialysis and transplant units. The 
following table presents a synoptic view of recent estimates. 
It is an expanded and slightly modified version of Table 1 
in Platt 1411. 
The quantitative significance of the age restriction in 
defining suitability for treatment of CRF patients can be 
better appreciated after we examine their age distribution. 
In forecasting future requirements, one should also keep in 
mind that the prevention of early deaths from diabetes and 
other diseases will increase the number of persons going into 
renal failure. 
1.5. Demographic and Socioeconomic Characteristics 
Knowledge of these characteristics is essential in deter- 
mining the most suitable form of treatment for CRF patients. 
For instance, socioeconomic conditions may preclude the possi- 
bility of home dialysis; very young patients are usually un- 
able to submit to the strict discipline of chronic dialysis, 
and for this and other medical reasons (e.g. growth) they are 
the most natural candidates for transplantation; persons living 
alone must rely on institutional care to a much greater extent 
than other patients, and so on. 
Available data (McCormick and Navarro [32]; Perlman et al. 
[40]) show that, by comparison with the population at large, 
the CRF population does not differ significantly with regard 
to sex distribution; but many more men receive transplants 
(and, probably, also dialysis treatment) than women. 
Given the chronic nature of the disease, one would expect 
that the CRF population differs significantly from the general 
population with respect to the age distribution. This is in- 
deed the case, and Table 2, taken from McCormick and Navarro 
[32], points this out quite clearly. 
Table 1. Estimates of the incidence of patients requiring 
treatment for chronic renal failure. 
Author 
Gottschalk 
Lipworth 
Sheil et al. 
Hallan and 
Harris 
Branch et al. 
Baltzan and 
Baltzan 
Branch et al. 
Site of study, 
publication date 
USA, l9G7 
San Francisco, 1968 
Australia, 1969 
USA, 1970 
Wales, 1970 
Saskatchewan, 1971 
Wales, 1971 
Method used 
Mortality data. 
Mortality data, 
hospital records for 
one-third sample of 
city population over 
two ysar period. 
Patient care: 190 
patients treated for 
a two-year period 
from a population of 
2,000,000. 
Expert opinion, 
mortality data. 
Hospital lab data 
and physician survey 
for 120,000 people 
over three-year 
period. 
Patient care: 105 
patients treated 
over 5 Y4-year 
period. 
Patient care: 56 
patients treated in 
one year from popu- 
lation of 2,600,000. 
Age group to 
be treated 
15-54 
15-64 
15-55 
15-54 
15-50 
5-65 
15-55 
New patients per 
million population 
3 5 
26 
Table 1 (continued) 
Friedlander 
Pendreigh 
et al. 
Rosenheim 
McCormick 
and Yavarro 
Modan et al. 
Baltimore, 1971 
Scotland, 1972 
Northern Ireland, 
1972 
UK, 1972 
Scotland, 1973 
Israel, 1973 
Death certificates. 
Physician survey, 
hospital records, 
death certificates. 
Physician survey, 
hospital data for a 
three-year period. 
Survey of patients in 
dialysis-transplant 
units between Jan. 1, 
1967 and May 1, 1970. 
Review of literature. 
Physician survey in 
Southeast region of 
Scotland between 
July 1, 1968 and 
June 30, 1969. BU 
level used: 2 100 mgX. 
Hospital lab data and 
hospital records for 
all CRF patients 
(BU 2 60 mg$) , 60 years 
of age or younger, 
over a two--year period 
1965-1966. 
57.4 (in 1965) 
58.0 (in 1966) 
k a, 
rd C 
a* 
g :  Urn 
A median age of forty-five years for chronic uremic 
patients has often been suggested. The Scottish data indi- 
cate a somewhat higher value for this parameter, and the mor- 
tality figures collected by the Research Triangle Institute 
(U.S. Department of Health, Education, and Welfare [501) show 
an even more skewed distribution: of the 50,000 yearly deaths 
due to uremia in the United States, 79% are in the age group 
above fifty-five, 19% in the fifteen to fifty-four age group, 
and 2% in the age group zero to fourteen. The fact that most 
persons in whom renal failure develops are elderly has far- 
reaching policy implications. As the comparative data of 
Table 1 imply, age limits have traditionally played a crucial 
role in the definition of criteria for admission to treatment 
of CRF patients. But recent institutional changes, especially 
in the Social Security legislation of many countries, tend to 
weaken, or even to abolish, such constraints. Since older 
pstients are generally unsuited for transplantation, it is to 
be expected that the patient load for dialysis centers will 
greatly increase in the near future, even if the proportion 
of medically qualified patients is smaller in the older age 
groups. For further discussion of this point, see section 
3 below. 
Published information on socioeconomic characteristics 
of CRF patients is quite limited. Statistics such as those 
published by the Kidney Transplant Registry or by the European 
Dialysis and Transplant Association, being largely research 
oriented, do not include occupational data, nor descriptive 
information indicative of social class. McCormick and Navarro 
[32] have found that CRF was underrepresented in the category 
of white collar workers and skilled laborers, corresponding 
to the standard British Social Classes I1 and I11 (this group 
represents 65% of the population at risk, but only 39% of the 
CRF population). However, given the high proportion (24%) 
of patients for which incomplete or no information on socio- 
economic charackeristics could be obtained, these findings 
have only limited significance. 
In countries that are not racially homogeneous, the 
racial composition of the population may also be an important 
factor in calculating treatment requirements. In the United 
States, for instance, total mortality from renal disease is, 
according to U.S. Vital Statistics (1968), 43.8/100,000 for 
nonwhites, against a rate of about 25/100,000 for the white 
population. Mortality from hypersensitivity diseases, includ- 
ing chronic glomerulonephritis, in 1967 was 4/100,000 in whites 
and 9.6/100,000 in nonwhites. Friedlander's analysis of the 
data for Baltimore, where 47% of the population is composed 
of nonwhites, makes the significance of the racial factor 
quite obvious (Friedlander [15]). His estimates, shown in 
Table 1, are much higher, and present a greater spread, than 
any other published data; they probably reflect an underlying 
bimodal distribution. 
Treatment Modalities 
For a patient with irreversible kidney damage, two life- 
saving therapies are available: intermittent (hemo- or peritoneal) 
dialysis and transplantation. Conservative management, through 
drugs, diet, etc. is not really an alternative form of treat- 
ment for such patients, but can significantly contribute to 
the success of the other therapies. For dialysis, the main 
options are home or institutional treatment; in transplantation, 
there may be a choice between the use of an organ coming from 
a living or from a cadaver donor, 
Hemodialysis 
Extracorporeal dialysis is the older form of treatment. 
J.J. Abel, L.G. Rowntree, and B.B. Turner used it on animals 
ov-er sixty years ago. Neither cellophane, the material common- 
ly used today for the semipermeable membrane through which 
dia1;rsis takes place, nor heparin, an anticoagulant, were 
known at that time. 
The first use of hemodialysis in humans (Dr. W.J. Kolff 
in the Netherlands, 1944) marked the availability of cellulose 
acetate membranes in tube form, and of heparin as an artifi- 
cially produced anticoagulant. However, hemodialysis entered 
in common use in the treatment of chronic renal failure only 
in 1960-1961, with the introduction of the arteriovenous (AV) 
shunt. 
The dialysis systems in current use consist of a fluid 
preparation unit, and the dialyzer itself. Numerous monitors 
and fail-safe devices are incorporated in most dialysis machines. 
Artificial dialysis takes place by circulating blood on 
one side of a cellophane membrane, while the other side is 
bathed by a salt solution. The accumulated toxic products 
diffuse out of the blood, and the concentration and total 
amount of water and salts in the body fluids is adjusted by 
appropriate alteration in the composition of the bath fluid 
(dialysate). Dialysis is generally performed two or three 
times a week, each dialysis treatment lasting from six to 
sixteen hours. 
Present artificial kidneys only partially replace a nor- 
mally functioning kidney, except in relation to electrolytes 
and acid base. The difficulty of matching the performance 
of a healthy human kidney can be appreciated by considering 
that each kidney contains about a million filtration units, 
the glomeruli. Blood passes to a glomerulus and an ultra- 
filtrate is formed. This passes down the tubule which modi- 
fies it to produce urine. The glomerulus is an extremely per- 
meable filter. A substance with molecular weight of 5,000, 
e.g. inulin, is cleared from the blood as fast as creatinine, 
with a molecular weight of 113. The relative inefficiency of 
the artificial dialyzer is indicated by the fact that its 
clearance (ml/min) at a molecular weight of 5,000, may be in- 
ferior to that of a diseased kidney with a glomerular filtra- 
tion rate of 2 ml/min, or about one-fiftieth of the normal 
value (Coles [12]). With present equipment, clearance can be 
improved only be increasing surface area or treatment time, 
and there are definite limits to both. Moreover, normal 
kidneys perform important functions other than filtration and 
reabsorption. For instance, they produce several hormones, 
and convert vitamin D into its active form. The latter fact 
explains the close connection between renal failure and sub- 
sequent bone disease (osteodystrophy). 
2.2. Peritoneal Dialysis 
This form of dialysis exploits the fact that the human 
peritoneum, with a surface of between 1.5 and 2 m? (consider- 
ably greater than that of any of the hemodialyzers of today), 
behaves as an inert, semipermeable membrane. The technique 
of peritoneal dialysis is essentially a simple matter of ab- 
dominal paracentesis, and is usually performed at the bed side. 
After ensuring that the bladder is empty, a nylon catheter 
with a removable central stylet is introduced into the peri- 
toneal cavity. Either one or two liters of dialysis fluids 
are then instilled during each exchange, which normally lasts 
one hour (total treatment time varies between twelve and 
thirty hours) . 
The use of peritoneal dialysis on humans precedes hemo- 
dialysis. Ganter used it in Germany in 1923 for acute renal 
failure, and the technique was introduced in the United States 
twenty years later, again for treatment of acute cases. But 
problems of infection, particularly peritonitis, of fluid and 
electrolyte imbalance, and technical complications (including 
the production of a sterile infusion fluid for use with this 
type of equipment), represented major stumbling blocks for 
several decades. 
The outlook for peritoneal dialysis improved substantially 
when, in 1959, Maxwell, Boen and co-workers devised a completely 
closed automated sterile supply system to replace the open 
system with multiple one-liter bottles, and used repeated punc- 
tures instead of a constant indwelling catheter. The advent 
of biologically inert silicone-rubber catheters has also in- 
creased interest in the possibilities of long-term peritoneal 
dialysis for CRF treatment. Tenckhoff et al. [49] have ana- 
lyzed ten years' experience with peritoneal dialysis in sixty- 
nine patients whose ages ranged from three to seventy-eight 
years. Most patients were dialyzed three times a week (three- 
fourths of the 11,921 dialyses performed in total were done 
at home), for twelve hours overnight. Of the sixty-nine 
patients, thirty performed 3,166 dialyses with a single episode 
of p e r i t o n i t i s ;  t h e  remaining p a t i e n t s  had s even ty - t h r ee  p e r i -  
t o n e a l  i n f e c t i o n s  ( 0 . 6 %  of  a l l  d i a l y s e s  pe r fo rmed) .  There 
were no p e r i t o n i t i s  d e a t h s .  
Not a l l  workers  have o b t a i n e d  such good r e s u l t s ,  b u t  p e r i -  
t o n e a l  d i a l y s i s  i s  i n c r e a s i n g l y  becoming a n  i n t e r e s t i n g  a l t e r -  
n a t i v e  even f o r  c h r o n i c  t r e a t m e n t ,  e s p e c i a l l y  f o r  p a r t i c u l a r  
g roups  of  p a t i e n t s  such a s :  sma l l  c h i l d r e n ,  i n  whom blood 
a c c e s s  i s  d i f f i c u l t ;  p a t i e n t s  who have l o s t  a l l  blood a c c e s s  
f o r  hemodia lys i s ;  p a t i e n t s  l i v i n g  a l o n e  and f o r  whom una t t ended  
hemodia lys i s  would be  hazardous;  p a t i e n t s  who a r e  i n t e l l e c t u a l l y  
i n c a p a b l e  of  d e a l i n g  w i t h  t h e  compl ica ted  t e chn iques  of  hemo- 
d i a l y s i s ;  and p a t i e n t s  f o r  whom f a c i l i t i e s  f o r  hosp i t a l - ba sed  
d i a l y s i s  a r e  n o t  a v a i l a b l e ,  p a r t i c u l a r l y  t h o s e  awa i t i ng  t r a n s -  
p l a n t a t i o n  o r  r e t r a n s p l a n t a t i o n .  
The m a j o r i t y  of e x p e r t  op in ion  c o n s i d e r s  it u n l i k e l y  t h a t  
r e g u l a r  p e r i t o n e a l  d i a l y s i s  w i l l  e v e r  prove p r e f e r a b l e  t o  main- 
t enance  hemodia lys i s  ( M i l l e r  and T a s s i s t r o  [ 3 6  ]; Henry Jones  
[ 2 3 ] ;  b u t  i n  view of t h e  expec ted  l e v e l  of demand f o r  d i a l y s i s  
t r e a t m e n t ,  no p o s s i b i l i t y  should  be r e j e c t e d  w i thou t  a  sub- 
s t a n t i a l  body of up- to-date  ev idence .  The r e s u l t s  r e c e n t l y  
o b t a i n e d  w i t h  p e r i t o n e a l  d i a l y s i s  make randomized c o n t r o l  
t r i a l s  e t h i c a l l y  a c c e p t a b l e .  Table  3  compares, i n  q u a l i t a t i v e  
t e r m s ,  t h e  major  advan tages  and d i s advan t ages  of t h e  two forms 
of d i a l y s i s  t r e a t m e n t .  
Tab le  3 .  Comparison of  hemo- and 
p e r i t o n e a l  d i a l y s i s .  
Hemodialysis  
P e r i t o n e a l  
Advantages 
- S h o r t e r  d u r a t i o n  of 
t r e a t m e n t  
- R e l i a b l e  e l i m i n a t i o n  
of  m e t abo l i c  was te  
p r o d u c t s  
- Can be used a l s o  i n  
c a s e s  of stomach 
o p e r a t i o n s  and i n -  
f lammation o f  t h e  
per i toneum 
Disadvantages  
- Danger of  b l eed ing  
th rough  u se  of 
a n t i c o a g u l a n t s  
- Heavy demand on t h e  
c i r c u l a t o r y  sys tem 
- G r e a t e r  t e c h n i c a l  
comp l i ca t i on  of  t h e  
equipment; g r e a t e r  
demand on s t a f f  
a t t e n t i o n  
- Small  danger  of - Longer d u r a t i o n  of  
b l e e d i n g  t r e a t m e n t  
- Limi ted  demands - P r o t e i n s  l o s s  
on  c i r c u l a t o r y  sys tem 
- No need of a r t i f i c i a l  - Danger of p e r i t o n e a l  
v e s s e l s  i n f e c t i o n  
- P o s s i b i l i t y  of d r a i n -  - G r e a t e r  p a t i e n t  
i n g  l a r g e r  amounts o f  d i s c o m f o r t  
w a t e r  
- G r e a t e r  s i m p l i c i t y  of 
t h e  equipment and lower 
c o s t s  
2.3. Technical Innovations 
A number of recent developments in equipment and'clinical 
techniques show promise of being able to increase substantially 
the effectiveness of dialysis treatment in the near future. 
Much effort has been spent in the attempt to red-uce dia- 
lyzing time, and in many cases it has proved possible to 
reduce dialyzing time from thirty to about eighteen hours a 
week, with significant benefits for the rehabilitation prospects 
of the patients. Further reductions could probably be obtained, 
for instance by connecting several dialyzers in series (Coles 
[121), but there are physiological limits to the speed with 
which the organism can adapt to sudden changes in plasma 
composition. 
In the opinion of many experts, the most exciting innova- 
tion in recent years has been the development of sorption-based 
hemodialysis systems (Bultitude and Gower [lo]; T.M.S. Chang 
[ll]; The Lancet, August 24, 1974). This started with the 
work of Dr. H. Yatzidis, in the early 19601s, showing that 
activated charcoal absorbed creatinine. Professor T.M.S. Chang 
has designed a microcapsule artificial kidney, in which the 
patient's blood flows through a bed of 300 g. of microcapsules 
of activated charcoal, contained in a cylindrical chamber, 
8 cm. high and 10 cm. in diameter; it then returns through an 
air and clot trap to the system circulation. No blood pump 
is needed for patients with AV shunts. So far, fifteen chronic 
patients have been treated, three of them for more than six 
months each. The results indicate that, so far as the relief 
of uremic symptoms and the general feeling of well-being in 
the patient are concerned, two hours of this treatment are as 
effective as six hours of treatment with a more conventional 
hemodialyzer. However, a few problems, such as the removal 
of water, still exist. 
The trend toward smaller disposable dialyzers is contin- 
uing. A truly portable, miniaturized kidney machine, using 
cartridges for the dialysate, would represent a very important 
advance, but a real breakthrough in this direction is not yet 
in sight. 
The organization of dialysis treatment in the home of 
CRF patients, has become an important component of dialysis 
programs in a number of countries. In England and Wales, the 
Department of Health and Social Security has adopted the policy 
that CRF patients should be treated initially by hemodialysis 
at a hospital, acting as a regional renal unit, and subsequent- 
ly be discharged from the hospital, either with a successful 
transplant or as a trained home-dialysis patient (Grant and 
Whelpton [201). Even patients who receive successful kidney 
transplants have been supported for varying periods by home 
dialysis. Of the 1,500 patients being treated by hemodialysis 
in the United Kingdom, as of January 1973, nearly 900 (60%) 
were on home treatment. 
In the United States, the proportion of patients on home 
dialysis varies from almost 100% in the State of Washington, 
to 33% in New York State and 20% in Massachusetts (part of 
this variation is explained by institutional factors: in 
some states, major insurance policies cover center but not 
home dialysis). About 37% of the 7,305 patients on chronic 
hemodialysis reported to the U.S. National Dialysis Registry 
as of January 1, 1973 were being treated at home. 
If one were to extrapolate the present trend toward in- 
creasing reliance on the home treatment, it would indeed 
appear that institutional dialysis is bound to be reduced to 
a rather minor role in the service of research, training, 
i ~ d  transplantation. But the success of a large program of 
home dialysis depends on a number of factors, many of which 
are mtside the control of the health authorities. With in- 
creasing experience, these difficulties become more and more 
apparent. 
The patient and his official helper, usually the spouse, 
must be trained so that he may be able to treat himself and 
to take care of the machine. Given the level of technical 
complexity of hemodialysis equipment, successful training 
requires a certain level of intelligence, and considerable 
pedagogical skills on the part of the nursing and technical 
staff. 
A room in the patient's home must be set aside for this 
purpose, after the necessary alterations have been made. Al- 
ternative arrangements are necessary if suitable space inside 
the house is not available. The possibility which has been 
suggested, of installing a mobile unit outside the house 
(Grant and Whelpton [201), is often infeasible in an urban 
setting. 
A team of technicians must be organized to control the 
first home dialysis, ensure that the patient has a sufficient 
stock of the necessary materials (intravenous fluids, tubing, 
eparin, etc.), maintain the machine in good working condition, 
and provide other emergency services. The number of required 
technicians varies widely with geographical dispersion of the 
patients, nature of the terrain, road and traffic conditions, 
and the weather. 
A telephone line connecting the patient with the renal 
unit is absolutely necessary, and the possibility of bringing 
him back to the unit, in case of serious technical or medical 
complications, must be arranged under all possible circum- 
stances. Contingency plans must also be worked out to meet 
such eventualities as restrictions in electricity supplies 
caused by industrial action, power failure, extreme weather 
conditions, natural catastrophes, fire, and so on. 
Even under normal circumstances, patients occasionally 
have to return to the dialysis unit for a variety of reasons. 
Back up rates of 5% to 8% have been reported, when external 
shunts were used (Platt [411). Thus, about twenty home 
patients will keep one center bed in constant use. 
The benefits of home dialysis, when it is feasible, are 
of course quite substantial. They are economic (see below, 
section 3); medical (reduced danger of infections, especially 
hepatitis); psychological (greater self-reliance of the 
patient and possibility of choosing preferred periods of 
treatments; but problems arising out of fears of machine 
failure, lack of sleep, family tensions, etc. have been re- 
ported by Blagg et al. [61 and by Gordon [181 , among others) ; 
and logistical (reduced travel time for the patient). 
Mortality statistics do not reveal any clear-cut superiority, 
in terms of survival rates, of either home or institutional 
dialysis. The differences that have been reported can be 
explained both in terms of selection bias, the patients select- 
ed for home treatment being usually those with better prognoses, 
and of the fact that the high initial mortality has already 
occurred in the hospital centers where the patients are being 
trained for home dialysis. 
Experience with other organizational forms, in particular 
the satellite centers, is still too limited to justify even 
a tentative assessment. Undoubtedly, the strong research 
orientation still prevailing in most hospital units, has not 
stimulated the search for organizational structures that are 
adequate for the task of providing large-scale dialysis ser- 
vices. 
2.5. Transplantation 
This is the second major form of treatment of CRF. Kidney 
transplantation has made great progress since the "black years," 
back in the 19501s, described by the former surgeon-in-chief 
at Peter Bent Brigham Hospital in Boston (Moore [ 3 8 ] ) :  
"Several of the patients operated on for kidney transplanta- 
tion at Peter Bent Brigham Hospital during the 'black years1 
between the introduction of whole body radiation and the dis- 
covery of immunosuppressive chemotherapy were admitted with 
no kidneys whatsoever . . . . Repeated dialysis was then in 
an infant stage, and any concept of maintaining a person for 
weeks, months, or even years under dialysis alone was simply 
out of the question . . . . [Tlhe outlook without operation 
was nil, and standards for acceptability of operation were 
therefore lowered to give the patient at least some chance 
for recovery. In many of these early desperate attempts, 
experiences were gained which later made it possible to raise 
the standards of acceptability for other patients with less 
urgent situations." 
An important step forward was represented by the first 
successful transplantation between a nonidentical donor and 
recipient, performed by Dr. J. Murray in 1958 (the patient 
lived for five years). But in 1963, the general situation 
still presented "a dismal picture of repeated failures and 
only an occasional success" (Starzl [481) . 
The process of systematic assessment of the progressively 
improving results of kidney transplantation was greatly facil- 
itated by the creation, of the Human Kidney Transplant Registry 
in 1963 in Boston. Data from institutions in North America, 
Europe, Australia, and Japan were collected and analyzed on 
a yearly basis. The present Registry, the direct descendant 
of the first Boston Registry, operates under sponsorship of 
the American College of Surgeons, and receives funding from 
several institutes of the National Institutes of Health. In 
ln72, 246 institutions reported to the Registry, 135 from 
North America and 111 from other centers abroad, particularly 
in Ellrope and Australia. The llth [14] Report of the Registry 
includes data relating to 12,389 renal transplants, comprising 
experience from 1951 through 1972 (11,264 first transplants, 
1,019 second transplants, and 106 third and subsequent grafts). 
A notable innovation of the llth Report is its reference to 
five-year figures on survival and duration of function. 
The kidneys used for transplantation come either from a 
living donor (usually a parent or sibling), or from a cadaver. 
In the early years of kidney transplantation, transplants from 
living, nonrelated donors were relatively frequent. Today, 
such donors are generally considered unacceptable, both on 
ethical and on medical grounds, since all available statistics 
indicate that'the changes of success are higher with cadaver 
than with living nonrelated donors (see below). 
Medical efforts in recent years have been concentrated 
on ways of obtaining better donor-recipient matching, especially 
through careful tissue typing, and on post-operative treatment 
using benign immunosuppressant drugs, such as azathioprine. 
Other methods to reduce the immune response (e.g. antilymphocyte 
serum and extracorporeal irradiation of the blood) are still 
in the experimental stage. 
It has been estimated that about 16% of all the patients 
who annualy die from end-stage uremia are ideally suited for 
transplantation (Department of Health, Education, and Welfare 
[SO]). However, there are currently a number of major obstacles 
to greater use of renal transplantation from living donors. The 
use of living related donors raises serious moral questions, 
since the risks for the donor involve not only the possibility 
of future renal failure, but also hypertension and its associ- 
ated cardiovascular disorders. At any rate, such donors can 
provide only a limited number of kidneys. 
2 . 6 .  The Use of Cadaver Ridn.evs 
For t h e s e  r ea sons ,  and wi th  t h e  improvement i n  t r ansp lan -  
t a t i o n  therapy ,  non l iv ing  donors a r e  r a p i d l y  becoming t h e  most 
important  source  of  organs .  This  t r e n d  has been s t r o n g l y  r e i n -  
fo rced  by t h e  f i n d i n g  t h a t  a  second, o r  even a t h i r d ,  t r a n s -  
p l a n t  i s  p o s s i b l e  (and t h a t  sometimes t h e  second t r a n s p l a n t  
i s  much b e t t e r  t o l e r a t e d  than t h e  f i r s t ) ;  and by more exten-  
s i v e  use of a r t i f i c i a l  d i a l y s i s  t o  suppor t  t h e  r e c i p i e n t  du r ing  
t h e  phase of acu te  r e n a l  f a i l u r e ,  due t o  t h e  t u b u l a r  n e c r o s i s  
which may immediately fo l low t r a n s p l a n t a t i o n  of a cadaver kid-  
ney. 
The 1 1 t h  Report of  t h e  Human Renal Transp lan t  Regis t ry  
[ 1 4 ]  i n d i c a t e s  t h a t  63.4% of a l l  r e n a l  g r a f t s  r epo r t ed  t o  
t h e  r e g i s t r y  were from cadaver donors. This  f i g u r e  i s  heav i ly  
modified by United S t a t e s  exper ience ,  where only  52.6% of 
t h e  g r a f t s  came from t h i s  source .  I n  Europe, t h e  propor t ion  
of organs  from non l iv ing  donors r i s e s  t o  78.8%, and i n  
A u s t r a l a s i a  t o  98.3%. 
But, aga in ,  any d i r e c t  e x t r a p o l a t i o n  from t h e s e  d a t a  i s  
u n j u s t i f i e d ,  a s  long a s  a number of medical ,  l o g i s t i c a l ,  and 
l e g a l  problems remain unsolved. Among t h e  medical  problems 
a r e  t h o s e  of b e t t e r  h i s t o c o m p a t i b i l i t y  matching, development 
of new methods of immunosuppression and induc t ion  of t o l e r a n c e  
a t  b i r t h  o r  i n  t h e  a d u l t .  Techniques of assessment of cadaver  
kidneys f o r  t r a n s p l a n t a t i o n  a r e  s t i l l  i n  t h e i r  in fancy .  
Whether i n  s i t u  pe r fus ion  i s  d e s i r a b l e  and what i s  t h e  na tu re  
of t h e  i d e a l  p e r f u s a t e  i s  s t i l l  c o n t r o v e r s i a l ;  b u t  evidence 
i s  accumulating t h a t  it may be p o s s i b l e ,  by p e r f u s i o n ,  t o  
i d e n t i f y  t h o s e  cadaver  kidneys which w i l l  never  func t ion  
(Baxby e t  a l .  [ 4 ] ) .  
The main l o g i s t i c a l  problems a r e  t h o s e  of p r e s e r v a t i o n  
and t r a n s p o r t a t i o n .  Renal p re se rva t ion  can be d iv ided  i n t o  
fou r  d i f f e r e n t  t ypes  (Belzer  [ 5 ] ) :  s imple hypothermic s t o r a g e  
f o r  up t o  t e n  hours;  shor t - term p re se rva t ion  f o r  up t o  t h r e e  
days;  in te rmedia te - te rm p re se rva t ion  f o r  two t o  t h r e e  weeks; 
long-term p r e s e r v a t i o n  f o r  months o r  yea r s .  Using methods of  
cont inuous p u l s a t i l e  pe r fus ion ,  it has  proved p o s s i b l e  t o  
s t o r e  kidneys f o r  an average of twenty-nine hours (Un ive r s i t y  
of C a l i f o r n i a ,  San F r a n c i s c o ) ,  and kidneys have been success-  
f u l l y  t r a n s p l a n t e d  a f t e r  s t o r a g e  pe r iods  of up t o  t h r e e  days.  
Thus, shor t - term p r e s e r v a t i o n  provides  enough t i m e  t o  make 
t r a n s p l a n t a t i o n  of cadaver  kidneys a s emie l ec t ive  procedure,  
except  f o r  t h e  c r u c i a l  pe r iod  i n  which donor nephrectomy 
t a k e s  p l ace .  This  means, i n  p a r t i c u l a r ,  t h a t  t h e r e  i s  s u f f i -  
c i e n t  t i m e  t o  perform v i a b i l i t y  t e s t i n g  before  t r a n s p l a n t a t i o n ,  
and t h a t  a  sudden i n f l u x  of a l a r g e  number of cadaver  organs  
t o  a t r a n s p l a n t  c e n t e r  can be managed even by a smal l  team. 
However, the advantages of short-term preservation over 
simple hypothermic storage do not show up in the respective 
survival rates, since the extra time made available has not 
allowed, so far, improvement of donor-recipient matching by 
current methods of tissue typing. Only with intermediate-term 
storage will the more time-consuming methods of donor-recipient 
matching, such as mixed lymphocyte culture, become practical. 
Ideally, the kidney to be used in a transplant operation 
should be obtained from the so-called heart-beating cadaver, 
to avoid warm ischemia. Nephrectomy must be performed within 
one hour of death, and possibly sooner, and this is where the 
legal problems arise. In the absence of laws permitting an 
individual to bequeath any organ after his death, the consent 
of next of kin must be obtained. The recent decision by the 
surgeons of Addenbrooke's Hospital in Cambridge, England, to 
6 lscontinue kidney transplants (Jones [24] ) , arose from a 
disagreement with the Cambridge coroner over securing written 
perlL~i ssion from bereaved relatives. 
When the coroner insists upon written permission from 
the relatives before removal of the organs, many surgeons 
feel that they have no alternative but to abandon transplan- 
tation for the time being, since to use organs whose usefulness 
has been substantially reduced by long delay, can only harm 
a team's reputation by greatly lessening the probability of 
success. 
In every country, transplant teams are now experiencing 
an acute shortage of cadaver kidneys, in spite of the fact 
that the pool of potential donors probably exceeds half the 
population. In 1972 the British Department of Health and 
Social Security introduced a kidney donor card scheme (Ascott 
[l]). So far, the scheme has not had a great deal of impact 
on the supply of organs; at any rate, the existence of a card 
does not guarantee that kidneys will be removed at death, 
especially if the card is not readily apparant among the 
donor's immediate possessions. 
2.7. Survival Rates 
In discussing survival rates, one has to distinguish 
between patient survival and kidney survival, since the failure 
of a tranplanted kidney does not necessarily mean patient 
death. Data summarizing experience from 12,389 renal trans- 
plants performed from 1951 to 1972 are given in Table 4, taken 
from the 11th Report of the Human Renal Transplant Registry. 
The data for the four-year period 1967-1970 are also presented 
in graphical form to make the comparisons clearer (Figures 
1-4. ) 
Patient Survival and Transplant Function of First Transplant 
One Year Two Years Three Years Four Years r'ive 'xears 
,-I--.-- - - - -
% % % % % 
Year of Sample % Func- % Func- % Func- % Func- % Func- 
Transplant Size Alive tional Alive tional Alive tional Alive tional Alive tional 
I Sibling 1951-1966 
... ... ... 364 I:::: 202 85.8 73.8 81.7 69.6 . . . ... ... ... ... ... ... 87.4 74.0 ... ... 
Parent 
1951-1966 403 61.2 56.4 56.6 50.2 52.9 45.4 51.0 42.7 : : 1 
F 
I 
1967 148 74.9 72.2 69.1 63.9 64.6 58.4 63.0 55.5 
I:::: 
1972 155 81.7 76.4 ... ... ... ... ... ... ... ... 
Cadaver 
1951-1966 683 42.0 35.6 34.0 27.8 28.7 22.3 25.9 19.5 23.2 16.3 
Source: 11th Report of the Human Renal Transplant Registry [Id]. 
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I 
A thorough statistical analysis of these and related data 
must be deferred to a subsequent paper. However, it is quite 
clear from the information collected here that the differences 
between allograft survival curves for recipients of parental 
and of sibling transplants are not statistically significant. 
The same is true for the patient survival curves of recipients 
of parental and of sibling transplants, whereas the differences 
between the recipients of cadaver kidneys and the recipients 
of organs from living related donors are significant for both 
allograft and patient survival curves. 
Naturally, the data reported by the registry are highly 
aggregated, and conclusions based on them must be interpreted 
with care. Our inferences, however, are supported by other, 
independent studies analyzing the experiences of individual 
transplant centers over a number of years. For example, 
Lowrie et a1 [31], discuss the results of the transplant and 
dialysis program of the Peter Bent Brigham Hospital in 
Boston, for the eight-year period 1964-1971, and reach the 
same conclusions concerning the differences among survival 
rates in the three classes of patients. Also the absolute 
values of the survival rates are in good agreement with those 
reported by the Registry. 
Another conclusion of the Boston study is that dialysis 
patients (home dialysis) exhibit survival curves similar to 
those of recipients of transplants from living, related donors, 
but show significantly higher survival rates than recipients 
of cadaver allografts. This finding agrees with the data of 
the 1972 U.S. National Dialysis Registry, which found survival 
rates at one and two years, of 90% and 80%, respectively, for 
all dialysis patients. These values should be compared with 
the transplant survival rates for 1971 given in Table 4. 
A further interesting question is whether the organiza- 
tional characteristics of the transplantation centers, and in 
particular their size, has any influence on the survival rates. 
Information on this point would be useful in determining the 
optimal size of transplantation centers, and methods of alloca- 
tion of organs from kidney banks. 
Let us define, with the Transplant Registry, a small 
(large) center as one performing less than (at least) twenty- 
five transplantations per year. Considering only data from 
United States centers, we find that in 1965, the one-year 
survival rate for large centers was 54%, significantly higher 
than the 36% rate of the small centers. However, if we 
stratify the population of recipients according to the origin 
of the organ (sibling, patient, cadaver), it turns out that 
the difference is significant only for cadaveric and for parent 
d o n o r s ,  b u t  n o t  f o r  s i b l i n g  donors  (one-year  s u r v i v a l  r a t e s :  
68% f o r  l a r g e  c e n t e r s ,  65% f o r  s m a l l  c e n t e r s ) .  
I n  subsequen t  y e a r s ,  t h e  o v e r a l l  d i f f e r e n c e s  a r e  less 
pronounced: i n  1969 t h e  one-year s u r v i v a l  ra te  f o r  l a r g e  
c e n t e r s  was 78%,  a g a i n s t  74% f o r  s m a l l  c e n t e r s ;  i n  1970,  82% 
and 78%; and i n  1971,  83% and 7796, r e s p e c t i v e l y .  Disaggrega ted  
d a t a  f o r  t h e  l a t e r  y e a r s  w e r e  n o t  a v a i l a b l e  t o  check how much 
of  t h e  d i f f e r e n c e  c o u l d  b e  a s c r i b e d  t o  t h e  t y p e  of donor.  
111. Economic C o s t s  and Mechanisms o f  F inanc ing  
A s  t h e  t i t l e  of t h i s  s e c t i o n  s u g g e s t s ,  t h e  economic c o s t s  
o f  med ica l  t r e a t m e n t  canno t  b e  mean ingfu l ly  a s s e s s e d  indepen- 
d e n t  of  t h e  mechanisms of  f i n a n c i n g ,  and of  o t h e r  i n s t i t u t i o n a l  
f a c t o r s .  C o n t r a r y  o p i n i o n s  (Klarman e t  a l .  [ 2 7 ] )  are, I 
b e l i e v e ,  i n c o r r e c t  and t h e  c a s e  of  CRF shows c l e a r l y  why t h i s  
i s  so .  
A s i t u a t i o n  i n  which t h e  c o s t s  of  a r t i f i c i a l  d i a l y s i s  
and t r a n s p l a n t a t i o n  a r e  covered  by p r i v a t e  h e a l t h  i n s u r a n c e ,  
v o l u n t a r y  c o n t r i b u t i o n s ,  and a  v a r i e t y  of  p u b l i c  s o u r c e s  ( e .g .  
V e t e r a n s  A d m i n i s t r a t i o n ,  S t a t e  Medicaid programs, Medicare and 
F e d e r a l  r e s e a r c h  f u n d s ,  i n  t h e  Uni ted  S t a t e s )  d i f f e r s  q u a n t i -  
t a t i v e l y  and u u a l i t a t i v e l y  from one i n  which such c o s t s  a r e  
covered  by s o c i a l  s e c u r i t y .  
Because p a t i e n t  s e l e c t i o n  based on c r i t e r i a  o t h e r  t h a n  
s t r i c t l y  medica l  o n e s  i s  v i r t u a l l y  i m p o s s i b l e  under  s o c i a l  
s e c u r i t y  a r rangements ,  a  s u b s t a n t i a l  and c o n s t a n t l y  i n c r e a s i n g  
p r o p o r t i o n  of  t h e  CRF p a t i e n t s  b e i n g  t r e a t e d  would be  composed 
of  e l d e r l y  p a t i e n t s  ( s e e  s e c t i o n  1 . 5  a b o v e ) .  I n  f a c t ,  even a  
l i m i t e d  r e l a x a t i o n  of age  l i m i t s  c a n  have a  s i g n i f i c a n t  impact  
on p a t i e n t  c a s e l o a d .  For i n s t a n c e ,  t h e  sudden jump i n  t h e  
e s t i m a t e  of CRF p a t i e n t  c a s e l o a d  i n  t h e  S t a t e  of Washington, 
from s e v e n t e e n  p e r  m i l l i o n  i n  1969 t o  t h i r t y - f i v e  p e r  m i l l i o n  
i n  1971, can  p r o b a b l y  be  e x p l a i n e d  i n  t h i s  way. 
Few p a t i e n t s  i n  t h e  o l d e r  age  group ( s i x t y  y e a r s  and above) 
can  undergo t r a n s p l a n t a t i o n .  On t h e  o t h e r  hand,  w i t h  improve- 
ment i n  d i a l y s i s  t e c h n i q u e s ,  o l d  age  (and p e r h a p s  even young 
a g e ,  s a y  two t o  f o u r t e e n  y e a r s )  can  no l o n g e r  be c o n s i d e r e d  
a  c r u c i a l  f a c t o r  i n  d e t e r m i n i n g  medica l  s u i t a b i l i t y  (Meadow 
e t  a l .  [35]  ; Ghautous [17] ) . Thus, t h e  v a s t  m a j o r i t y  of 
e l d e r l y  CRJ? p a t i e n t s  would be  t r e a t e d  by d i a l y s i s  ( i n  t h e  
h o s p i t a l ,  moreover,  s i n c e  home d i a l y s i s  would b e  i m p o s s i b l e  
f o r  most of  them) .  
Because t h e  aged p a t i e n t  r e q u i r e s  more c a r e ,  t h e  burden 
on h o s p i t a l  f a c i l i t i e s  and on t h e  s t a f f  w i l l  i n c r e a s e  s i g n i -  
f i c a n t l y ;  r e h a b i l i t a t i o n  problems w i l l  b e  much more s e v e r e .  
P r e s e n t  d i f f i c u l t i e s  i n  a t t r a c t i n g  a  s u f f i c i e n t  number of  
n e p h r o l o g i s t s  and o t h e r  med ica l  p e r s o n n e l  t o  d i a l y s i s  c e n t e r s  
(Platt [411), would be compounded in a situation in which a 
majority of the patients are elderly. 
The effects of the mechanism of financing can be felt 
in many other ways. For instance, under Section 299-1 of the 
Social Security Amendments of 1972 (so-called HR-l), costs of 
dialysis or transplantation in the United States are reimburs- 
able only after the first ninety days of care. This creates 
an incentive to delay transplantation, while the patient waits 
on dialysis for three months. The most favorable moment for 
transplantation may thus be lost, because of "holding dialysis" 
which could induce sensitization to antigens in transfused 
blood (Friedman and Kountz [16] ) . 
In discussing home dialysis (section 2.4), I have already 
mentioned how some insurance policies cover hospital, but not 
home dialysis, thus significantly affecting the mix of the 
two modes of treatment, and the overall cost of CRF. The same 
restriction appeared in several of the State Medicaid programs 
in the United States (Platt [41] ) . 
To estimate the economic cost of CRF, one must take into 
consideration, among other factors, the indirect costs of 
morbidity, defined as the difference between predisease earn- 
ings and earnings during the course of the disease. This 
component of cost may then be expressed as a percentage of 
predisease earnings, and calculations have been made on the 
basis of a 25% loss in income (Hallan and Harris [221). 
However, under a system of social security or social insurance, 
it may be advantageous for the chronic dialysis patient, es- 
pecially if he is married, to give up his job altogether in 
order to receive an invalid pension. 
Thus, no meaningful cost estimates can be derived, with- 
out taking into consideration financing mechanisms and other 
institutional aspects of the problem. For this reason, not 
to mention the distortions introduced by recent inflation and 
soaring costs, published cost figures for hospital and home 
dialysis and for transplantation must be interpreted with 
great care. 
Using data collected by the Gottschalk Committee, the 
following estimates have been calculated (Klarman et al. [271). 
Table 5. Present value of expenditures and life years gained 
per member of cohort embarking on transplantation 
and on center and home dialysis (discount rate: 6%). 
Present Value of Cost/Life 
Modality Expenditures Life Years Gained Year 
Dialysis $ 104,000 9 $ 11,600 
Center 104,000 9 11,600 
Home 38,000 9 4,200 
Mean 71,000 9 7,900 
Transplantation 44,500 17 2,600 
Adjusted for 44,500 
Quality (+ 25% 
of life years) 
The values given in the table correspond to an average 
yearly cost of $14,000 for hospital dialysis, $5,000 for home 
dialysis, and $13,000 for transplantation. These figures agree 
fairly well with those given by Hallan and Harris [221. 
British costs calculated at about the same time (Kerr [251), 
put the cost of dialysis per patient at about 52,000 for capi- 
tal costs and 51,400 as the yearly running costs. More recent 
estimates put the yearly cost of hospital dialysis at $15,000 
to $25,000 while the cost of home dialysis has remained at the 
$5,000 level (Friedman and Kountz [161), a revealing indica- 
tion of the dynamics of personnel costs. Unpublished figures 
for the United Kingdom, expressed in 1972 prices and using a 
discount rate of 101, indicate a cost per patient per annum 
of approximately 55,600 for hospital dialysis, and 53,400 
(plus an initial cost of 51,300) for the home treatment. 
The estimates appearing in Table 5 can be misleading in 
yet another sense. The cost-effectiveness ratios given there 
point very definitely to transplantation as the optimal policy 
for the treatment of CRF. However, in the words of two well- 
known medical experts, "The reality facing the treatable 
uremic patient in mid-1973 is that his present alternatives 
remain either home hemodialysis or outpatient-center hemo- 
dialysis" (Friedman and Kountz [161). The point of general 
methodological interest here is that cost-effectivenes or 
cost-benefit ratios are of little use to the policy maker if 
they are not preceded by a careful exploration of the feasibil- 
ity domain, since they can vary quite significantly with the 
scale of the program and with the magnitude of the effort re- 
quired to overcome presently binding constraints. 
IV. Est imat ing  Long-Term Requirements 
Since any f u t u r e  program f o r  t h e  t rea tment  of CRF w i l l  
have t o  r e l y  t o  a  l a r g e  e x t e n t  on hemodialys is ,  it i s  impor- 
t a n t  t o  e s t i m a t e  program requirements  under v a r i o u s  admission 
p o l i c i e s  and f o r  d i f f e r e n t  t ime hor izons .  The p o s s i b i l i t i e s  
of t r a n s p l a n t a t i o n  (and r e t r a n s p l a n t a t i o n )  must a l s o  be taken 
i n t o  account s i n c e  t h e  r a t e  of t r a n s p l a n t a t i o n  i s ,  t o  a  ce r -  
t a i n  e x t e n t ,  a  d e c i s i o n  v a r i a b l e  and w i l l  a f f e c t  t h e  s i z e  of 
t h e  d i a l y s i s  pool. 
The model t o  be d i scussed  i n  t h i s  s e c t i o n  has  consider-  
a b l e  f l e x i b i l i t y  i n  t h e s e  r e s p e c t s ,  and can accommodate d i f f e r -  
e n t  hypotheses concerning s u r v i v a l  r a t e s ,  t r a n s p l a n t a t i o n  r a t e s ,  
admission c r i t e r i a ,  and long-term epidemiological  and demo- 
g raph ic  t r e n d s .  The popula t ion  of p a t i e n t s  on ch ron ic  d i a l y s i s  
i s  d iv ided  i n t o  k  s t r a t a  o r  s t a t e s ,  according t o  t h e  l eng th  
of t rea tment .  A p a t i e n t  i s  s a i d  t o  be i n  s t a t e  S i  i f  he has 
been on d i a l y s i s  f o r  more than i-1 and no more than  i yea r s ,  
f o r  i = 1 , 2 ,  ..., k-1; Sk i s  i n t e r p r e t e d  a s  "k o r  more yea r s  
on d i a l y s i s . "  D i f f e r e n t  cho ices  of t i m e  u n i t s  a r e ,  of course ,  
pos s ib l e .  I t  should be noted t h a t  t h e  number of y e a r s  a  
p a t i e n t  i s  on d i a l y s i s  has  more than  a  pure ly  temporal  conno- 
t a t i o n ,  s i n c e  t h e  passage of t i m e  u s u a l l y  imp l i e s  a  s t eady  
d e t e r i o r a t i o n  i n  h i s  phys i ca l  cond i t i on .  
A p a t i e n t  i n  s t a t e  S i  i n  a  given yea r  can move t o  s t a t e  
Si+l  i n  t h e  nex t  y e a r ,  o r  he can d i e ,  o r  undergo a  t r ansp lan -  
t a t l o n .  I f  t h e  t r a n s p l a n t  f a i l s ,  t h e  p a t i e n t  can r e t u r n  t o  
d i a l y s i s ,  wi th  t h e  p o s s i b i l i t y  of a  second t r a n s p l a n t  l a t e r  
on. 
The s t a t e s  S i ,  i = 1 , 2 ,  ..., k,  form t h e  nonabsorbing p a r t  
of t h e  process .  The p r o b a b i l i t y  of t r a n s i t i o n  from S i  
i s  P i j ,  and P = Cpi j I  i s  t h e  corresponding s u b s t o c h a s t i c  ma r i x .  
SL i s  t h e  absorbing s t a t e  t o  which t h e  p a t i e n t  moves when he 
l e a v e s  d i a l y s i s ,  because of dea th  o r  t r a n s p l a n t a t i o n .  
R ( T )  denotes  t h e  i n p u t  t o  t h e  system a t  t ime T. I t  i n -  
c l u d e s  new CRF p a t i e n t s  who a r e  accepted f o r  d i a l y s i s ,  p a t i e n t s  
who resume d i a l y s i s  a f t e r  t h e i r  a l l o g r a f t  has f a i l e d ,  and 
p a t i e n t s  t r a n s f e r r e d  from o t h e r  systems. New p a t i e n t s  e n t e r  
t h e  system i n  S1; t r a n s f e r s  a r e  placed i n  t h e  same s t a t e  they  
occupied i n  t h e  c e n t e r  of o r i g i n .  Transp lan t  f a i l u r e s  could 
be ass igned  t o  t h e  s t a t e  they  occupied a t  t h e  t ime of t r ans -  
p l a n t a t i o n ,  o r  perhaps t o  a  l a t e r  s t a t e ,  t o  account f o r  t h e  
nega t ive  phys i ca l  e f f e c t s  of t h e  o p e r a t i o n  and of immunological 
suppress ion ,  and f o r  t h e  l i k e l y  d e t e r i o r a t i o n  i n  h i s  psycho- 
l o g i c a l  cond i t i ons  (Baxby e t  a l .  [ 4 ]  ) . 
The new a r r i v a l s  a r e  d i s t r i b u t e d  among t h e  d i f f e r e n t  non- 
absorbing s t a t e s  according t o  a  " r ec ru i tmen t  d i s t r i b u t i o n "  
k 
- p - p i  1 poi = 1. All recruits are supposed to join 
i=l 
the system at the beginning, and all dead and transplanted 
patients to leave it at the end of each year. These assump- 
tions are, of course, unrealistic but they will not seriously 
affect our conclusions, particularly for the long-run results, 
A potentially more serious assumption is that of the 
time-independence of the transition probabilities. However, 
given the present state of knowledge, it would be extremely 
difficult to specify how the probabilities might change over 
time. Because of advances in medical science and in technology, 
one would expect some improvement in the probabilities of sur- 
vival. At the same time, the progressive relaxation of the 
criteria of "medical suitability" has the opposite effect and 
available data do not allow any firm conclusion as to what the 
net result might be. Something more can perhaps be said about 
tne dependence of the transition probabilities on the age 
group to which the patient belongs. It may be advisable to 
use different matrices P for different age groups, especially 
if the elderly form a substantial part of all dialysis patients. 
The basic structure of our model can be represented as 
follows: 
Let ni (T) be the number of patients in Si at time T. The 
initial distribution of patients in the different nonabsorbing 
, .. states is given by the vector g (0) = (nl (01 n2 (01,. ,nk (01 . 
The values of ni (01, i = I,.. . ,k, are assumed to be known. 
k 
N(T) = 1 ni(T) is the total number of dialysis patients at 
. _I 1=I - 
time T. For T > 0, the ni(T) are random variables. Elementary 
calculations show that the expected number of patients in Si 
at time T+1, denoted by ni(~+l), is given by the formula 
R(T) is supposed to be known, at least in the mean value sense. 
- 
Thus, ni(T) can be computed recursively for all T's. Writing 
(1) in matrix notation: 
we find 
where PO is the unit matrix. 
In order to evaluate (~2) explicitly, it is necessary to 
make some assumptions about the functional form of R(T). Two 
cases are particularly relevant here: 
a) R(T) = R (constant input; for R = 0 the model can be 
used for a cohort analysis); 
T b) R(T) = Rx , x > 1 (geometric growth) . 
In the constant case, (2) becomes 
For the case of geometric growth, the expression is 
T T (x I-P 1 
Notice that the existence of the inverses (I-PI-' and 
(XI-PI-' is assured by the fact that the matrix P is substo- 
chastic, and hence all its eigenvalues are between 0 and 1. 
In the particular case under discussion, P is actually upper 
triangular, and the elements of its main diagonal (its eigen- 
values) are all equal to zero, except for p which is strictly 
between 0 and 1. kk 
P a r t i c u l a r  i n t e r e s t  i s  a t t a c h e d  t o  t h e  a sympto t i c  behav ior  
of  t h e  system. For T  -+ equa t i on  ( 3 )  becomes 
w h i l e  i f  R(T1 -+ m ,  a s  i n  t h e  c a s e  of  geomet r i c  growth,  t h e  
s i z e  of  t h e  system w i l l  obv ious ly  i n c r e a s e  beyond a l l  bounds. 
By well-known r e s u l t s  i n  t h e  t h e o r y  of  ab so rb ing  Markov 
c h a i n s ,  eq u a t i o n  ( 5 )  r e p r e s e n t s  a  c o n d i t i o n  of  s t e a d y  s t a t e ,  
i n  which t h e  number of p a t i e n t s  e n t e r i n g  t h e  sys tem e q u a l s  
t h e  number of t h o s e  l e a v i n g  it. I t  i s  c l e a r  from e q u a t i o n  
( 5 )  t h a t  t h e  i n i t i a l  d i s t r i b u t i o n  of  p a t i e n t s ,  g ( 0 ) ,  does  n o t  
a f f e c t  t h e  l i m i t i n g  s i z e  and s t r u c t u r e  of t h e  system. 
Using methods due t o  P o l l a r d  ( P o l l a r d  [43 ] ;  Bartholomew 
[ 3 1 ) ,  one can  a l s o  c a l c u l a t e  t h e  v a r i a n c e s  and c o v a r i a n c e s  
of  t h e  numbers of  p a t i e n t s  i n  t h e  d i f f e r e n t  states.  These 
methods presuppose  t h a t  t h e  i n p u t  t o  t h e  sys tem i s  s t o c h a s t i c -  
a l l y  independent  of  t h e  movement of p a t i e n t s  w i t h i n  t h e  system, 
T h i s  h y p o t h e s i s  i s  n o t  q u i t e  t r u e  i n  o u r  c a s e ,  s i n c e  t r a n s -  
p l a n t  f a i l u r e s  go ing  back t o  d i a l y s i s  a r e  counted w i t h  t h e  new 
a r r i v a l s .  However, t h e  dependence i s  r a t h e r  weak (of t h e  
12,389 t r a n s p l a n t s  r e p o r t e d  by t h e  T ransp l an t  R e g i s t r y  i n  1973, 
o n l y  9% w e r e  second o r  t h i r d  t r a n s p l a n t s ,  a  s l i g h t  i n c r e a s e  
from t h e  7% v a l u e  observed i n  1 9 6 7 ) ,  and it shou ld  n o t  s e r i o u s l y  
a f f e c t  t h e  a n a l y t i c  r e s u l t s .  T h i s  q u e s t i o n  w i l l  be  i n v e s t i g a t e d  
i n  a  f u t u r e  p ap e r ,  where t h e  r e s u l t s  of  c a l c u l a t i o n s  performed 
under  a  v a r i e t y  of  hypo theses ,  w i l l  a l s o  be r e p o r t e d .  
I s h a l l  conc lude  t h i s  s e c t i o n  w i t h  a  sma l l  numer ica l  
example, where t h e  f o l l owing  model i s  assumed: 
The i n i t i a l  d i s t r i b u t i o n  of  p a t i e n t s  need n o t  be  s p e c i -  
f i e d  s i n c e  I s h a l l  examine o n l y  t h e  a s y m p t o t i c  r e s u l t s ,  I t  is  
assumed t h a t  when t r a n s p l a n t a t i o n  i s  p o s s i b l e ,  it w i l l  u s u a l l y  
b e  performed w i t h i n  t h e  f i r s t  two y e a r s  of  d i a l y s i s  t r e a t m e n t .  
Suppose t h a t  20,000 CRF p a t i e n t s  e n t e r  t h e  sys tem e a c h  y e a r ,  
t o  be  t r a n s p l a n t e d  o r  t r e a t e d  by d i a l y s i s .  T h i s  c o r r e s p o n d s  
t o  40% of a l l  p a t i e n t s  who d i e  of c h r o n i c  uremia e a c h  y e a r  i n  
t h e  Uni ted  S t a t e s .  S i n c e  
e q u a t i o n  ( 5 )  g i v e s  t h e  f o l l o w i n g  s t e a d y - s t a t e  s t r u c t u r e :  
Under o u r  a s sumpt ions ,  t h e  t o t a l  number of  p a t i e n t s  i n  t h e  
sys tem each  y e a r  w i l l  t h u s  be  122,200,  of  which no more t h a n  
12 ,000  c o u l d  p robab ly  b e  t r a n s p l a n t e d .  P u t t i n g  t h e  c o s t  of  
d i a l y s i s ,  r a t h e r  c o n s e r v a t i v e l y ,  a t  $15,000 p e r  p a t i e n t - y e a r  
( c u r r e n t  p r i c e s ) ,  t h e  t o t a l  y e a r l y  c o s t  would amount t o  a b o u t  
$1,650,000,000.  I f  it i s  assumed t h a t  one p h y s i c i a n ,  two 
n u r s e s  and t h r e e  o r  f o u r  t e c h n i c i a n s  and a i d e s  are r e q u i r e d  
f o r  e v e r y  t e n  p a t i e n t s  on d i a l y s i s  (U.S. Department of H e a l t h ,  
Educa t ion ,  and Wel fa re  [ 5 0 ] ) ,  such a program would e v e n t u a l l y  
r e q u i r e  11,000 n e p h r o l o g i s t s ,  22,000 s p e c i a l l y  t r a i n e d  n u r s e s ,  
and more t h a n  40,000 t e c h n i c i a n s .  These r e q u i r e m e n t s  would 
p robab ly  exceed any r e a l i s t i c  manpower c o n s t r a i n t  and would, 
i n  any e v e n t ,  l e a d  t o  s e v e r e  s h o r t a g e s  i n  o t h e r  p a r t s  of  t h e  
h e a l t h  c a r e  system. 
S t a t e  
Number of  P a t i e n t s  
S1 S2 S3 S4  S5 
20,000 14,000 9,800 7 ,840 70,560 
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